I prosecuted sex predators. Trump is one. I shut down for-profit scam colleges. He ran one. I held big banks accountable. He's owned by them. I'm not just prepared to take on Trump, I'm prepared to beat him.

Another stellar Nature Medicine paper about the microbiome in RCC from a randomized prospective clinical trial from Sumanta K. Pal, MD, FASCO group with 1st authors Hedyeh Ebrahimi Nazli Dizman. Big congrats to this group !

Cancer care is calling for action. ⚠️Oncologists and their patients are on the line. “Unfortunately in many cases, the cancer has progressed and patients present advanced cancers by the time they meet me.”- Doreen Ezeife

So excited to see Terry Friedlander on the stage at #GUMOC24 #CUA24 Canadian Urological Association. This is his take on bladder cancer. Something happening new with even new data this week #NIAGARA neoadjuvant Durva! Awaiting the study details! #Victoria 🇨🇦

Off to a great start at the Canadian Urological Association 79th Annual Meeting in beautiful Victoria, B.C. #kidneycancer #CUA24

#GUMOC24 the CUA proudly helps organize the Genito-urinary medical oncologists of Canada meeting as we strive to become the Voice of urologic oncology in Canada. #CUA24

Cancer care is calling for action. ⚠️ Oncologists and their patients are on the line. Government needs to "address recruitment, retention and resource allocation in order for us to deliver the care our fellow Albertans deserve in this province." - Dr. Jan Willem Henning

Thank you Michael J. Fox for making our dream come true 🩵

Amazing performance by the stellar Genitourinary Cancer Research Team @CityofHope team’s junior investigators👉Two back to back Nature Medicine original research articles from their IIT studies. Congrats Hedyeh Ebrahimi Nazli Dizman & team and the mega-mentor Sumanta K. Pal, MD, FASCO Cc ASCO OncoAlert Uromigos KidneyCAN

The Uromigos country podcasts 🇩🇪 🇯🇵 🇳🇱 🇨🇦 for the 🏆🏆🏆 are complete. Who did you like the best? The number of votes here will be added to the number of listens. The winner will come to #nashvillelive and take on team LA Petros Grivas Tanya Dorff Sumanta K. Pal, MD, FASCO Photos below !!

Brilliant insights from Tom Powles Barts Cancer Institute (Queen Mary). Excellent use of Twitter polls to reconcile tough clinical scenarios (eg IO rechallenge following adj pembro). Shocking to hear rates of IO receipt in real world series - great point from Tom - use the best tx first. Toni Choueiri, MD

1/5 Excited to share our @MsaouelLab clinical analysis of 135 patients with #RenalMedullaryCarcinoma treated MD Anderson Cancer Center over 20 years 👉sciencedirect.com/science/articl… #endRMC #rarecancers Kidney Cancer Chris Johnson Foundation Inc. RMC Alliance R.M.C. Inc Rare Cancer Research Foundation + Pattern.org The Renal Medullary Carcinoma Research Foundation KCCure

More evidence that PD(L)1 re-challenge should be avoided in renal cancer. Tivozanib+ Nivo showed no ⬆️ in efficacy v.s Tivo alone in PD(L)1 pretreated RCC pts. ⬇️ Tivo dose in study arm requires consideration. This has implications post adjuvant pembro prnewswire.com/news-releases/…

A courageous and selfless decision. The President did what he’s done for the last four years - he listened to the American people and put the country’s interests ahead of his own. The exact opposite of Donald Trump.

Tonight, I am proud to have earned the support needed to become our party’s nominee. Over the next few months, I'll be traveling across the country talking to Americans about everything on the line. I fully intend to unite our party and our nation, and defeat Donald Trump.

CHMP gives a positive recommendation for Enfortumab Vedotin and Pembrolizumab in 1st line advanced UC. Paving the way for use in Europe. merck.com/news/merck-rec…

MODERN (A032103) is open and enrolling! Available through the CTSU. Bladder Cancer Advocacy Network World Bladder Cancer Patient Coalition Alliance for Clinical Trials in Oncology ECOG-ACRIN Cancer Research Group SWOG Cancer Research Network CCTG National Cancer Institute UroToday.com Natera Alan Tan Stephanie Berg Society for Immunotherapy of Cancer International Society of Liquid Biopsy

Abstract titles for #ESMO24 now online! Full NICHE-3 cohort (59 pts with dMMR colon cancer treated with neoadj nivo/rela) will be presented in proferred paper session + more neoadj IO from Imhotep, and wonderful Jenny Seligmann as discussant. Stay tuned for more exciting💥💥💥news!

Starting tomorrow in Yokohama, Japan, #ASCOBT24. Check below this wonderful meeting brought to you by ASCO meetings.asco.org/meetings/2024-… Mandy Davis Aitken Julie Gralow Clifford Hudis Lillian Siu

Program Chair Melvin LK CHUA opening Day 3 of #ASCOBT24, with keynote Dr Shimon Sakaguchi dissecting Treg biology as a strategy of tumor immunity ASCO